ARCA (Anti-Reverse Cap Analog)

Catalog #: 366-10016

ARCA Ammonium Solution (100 mM). ARCA is used for co-transcription capping of mRNA and producing cap transcripts that are modified to ensure only positive incorporation since ARCA.

Specifications

Size	10 µL, 50 µl, 100 µl
Estimated Lead Time	3-5 business days
Purity	≥95%
Molecular Weight (kDa)	817.4
Format	Clear colorless solution
Concentration (lot specific)	100mM ± 3mM
Endotoxin Level	<1 EU/ml
Shipping Type	Blue ice
Storage	-20°C

Description

Introduction

The vast majority of eukaryotic mRNA 5' end m7G cap structures improve RNA stability and significantly enhance translation. Anti-Reverse Cap Analog (ARCA) is used for co-transcription capping of mRNA and producing cap transcripts that are modified to ensure only positive incorporation since ARCA. Conventional cap analogues have two 3 '-OH groups, from which RNA polymerases can initiate transcription, while the 3 '-OH group close to m7G in ARCA is replaced by -OCH3 (as shown in the figure above), RNA polymerases can only use the remaining 3'-OH groups, forcing ARCA to be positively incorporated to produce 100% translatable cap RNA. ARCA can be used in combination with our modified nucleoside triphosphate (Nl-Me-pUTP, pUTP). By following the conditions in this note, the capping rate can reach approximately 80% and the crude transcript can reach 2-2.5 mg/ml.

Other Information

λmax:

254 nm±2nm

Bioburden:

≤1 cfu/ml

Quality Control:

This preparation is free of DNase and RNase contamination. This batch of ARCA has been performance tested in transcription reaction.

Storage

-20°C

Featured Products